Pharmacy cooperative American Associated Pharmacies (AAP) revealed on Monday the launch of a definitive agreement for the acquisition of the remaining 50% interest in the joint venture of Arete Pharmacy Network.
Upon completion of the acquisition on 12 September 2018, Arete Pharmacy Network became a wholly owned subsidiary of American Associated Pharmacies.
Arete Pharmacy Network is a quality-focused national Pharmacy Services Administrative Organization (PSAO), concentrated on the success and profitability of independent and community pharmacies. It was formed in 2016 with a total of 2,250 stores and has since grown to over 2,800 pharmacies, making the fourth largest PSAO in the nation. In December 2016, it expanded its geographical footprint through the acquisition of RxPride to extend the benefits of its programmes and services.
AAP in partnership with its subsidiaries provide the tools and resources needed for members to improve their bottom line and differentiate themselves from competitors. The members not only receive savings on brand prescriptions, generic prescriptions and OTC products through the API warehouse and their negotiated prime vendor agreement, but they receive negotiated competitive managed-care contracts through the Arete Pharmacy Network.
Par Health launches generic version of Janumet XR tablets in US
EQL Pharma gains approval to sell Mellozzan in Kazakhstan
Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib
Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA
Kaiser Permanente reports study findings showing significant cost savings
Apotex receives Health Canada approval for a generic Ozempic equivalent
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules